These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 19755222)
21. Percutaneous Patent Foramen Ovale (PFO) closure in young patients with both cryptogenic brain infarction and PFO associated with Atrial Septal Aneurysm (ASA). Juliard JM; Abboud H; Aubry P; Brochet E; Sauguet A; Depoix JP; Philip Y; Messika-Zeitoun D; Lung B; Vahanian A; Amarenco P EuroIntervention; 2006 Nov; 2(3):326-9. PubMed ID: 19755308 [TBL] [Abstract][Full Text] [Related]
22. Patent foramen ovale closure using a bioabsorbable closure device: safety and efficacy at 6-month follow-up. Van den Branden BJ; Post MC; Plokker HW; ten Berg JM; Suttorp MJ JACC Cardiovasc Interv; 2010 Sep; 3(9):968-73. PubMed ID: 20850098 [TBL] [Abstract][Full Text] [Related]
23. Initial clinical experience with the Coherex FlatStent™ and FlatStent™ EF PFO closure system for in-tunnel PFO closure: results of the Coherex-EU study. Sievert H; Wunderlich N; Reiffenstein I; Ruygrok P; Grube E; Buellesfeld L; Meier B; Schofer J; Muller D; Jones RK; Gillam L Catheter Cardiovasc Interv; 2014 Jun; 83(7):1135-43. PubMed ID: 22815250 [TBL] [Abstract][Full Text] [Related]
24. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events. Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668 [TBL] [Abstract][Full Text] [Related]
25. Patent foramen ovale percutaneous closure: the no-implant approach. Butera G; Romagnoli E; Sangiorgi G; Caputi L; Chessa M; Carminati M Expert Rev Med Devices; 2008 May; 5(3):317-21. PubMed ID: 18452381 [TBL] [Abstract][Full Text] [Related]
26. Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke. Bronzetti G; D'Angelo C; Donti A; Salomone L; Giardini A; Maria Picchio F; Boriani G Int J Cardiol; 2011 Jan; 146(1):17-21. PubMed ID: 19487038 [TBL] [Abstract][Full Text] [Related]
27. Gore Helex septal occluder for percutaneous closure of patent foramen ovale associated with atrial septal aneurysm: short- and mid-term clinical and echocardiographic outcomes. Musto C; Cifarelli A; Fiorilli R; De Felice F; Parma A; Pandolfi C; Confessore P; Bernardi L; Violini R J Invasive Cardiol; 2012 Oct; 24(10):510-4. PubMed ID: 23043034 [TBL] [Abstract][Full Text] [Related]
28. Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophilia. Giardini A; Donti A; Formigari R; Bronzetti G; Prandstraller D; Bonvicini M; Palareti G; Guidetti D; Gaddi O; Picchio FM Am J Cardiol; 2004 Oct; 94(8):1012-6. PubMed ID: 15476614 [TBL] [Abstract][Full Text] [Related]
29. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525 [TBL] [Abstract][Full Text] [Related]
30. A novel system for transcatheter closure of patent foramen ovale: clinical and echocardiographic outcome comparison with other contemporary devices. Darsaklis K; Freixa X; Asgar A; Ibrahim R; Basmadjian A; DeGuise P; Garceau P Can J Cardiol; 2014 Jun; 30(6):639-46. PubMed ID: 24882535 [TBL] [Abstract][Full Text] [Related]
31. Transcranial doppler quantification of residual shunt after percutaneous patent foramen ovale closure: efficacy of the GORE(®) HELEX septal occluder. Sorensen SG; Smout R; Spruance SL J Interv Cardiol; 2011 Aug; 24(4):366-72. PubMed ID: 21492220 [TBL] [Abstract][Full Text] [Related]
32. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study. Luermans JG; Post MC; Schräder R; Sluysmans T; Vydt T; Vermeersch P; Chessa M; Onorato E; Goy JJ; Budts WI Catheter Cardiovasc Interv; 2008 May; 71(6):822-8. PubMed ID: 18324695 [TBL] [Abstract][Full Text] [Related]
33. Percutaneous atrial shunt closure using the novel Occlutech Figulla device: 6-month efficacy and safety. Van Den Branden BJ; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ J Interv Cardiol; 2011 Jun; 24(3):264-70. PubMed ID: 21198853 [TBL] [Abstract][Full Text] [Related]